Data Science in the News

Advanced Data Analytics for Proliferation Detection shares technical advances during two-day meeting

The Advanced Data Analytics for Proliferation Detection (ADAPD) program held a two-day virtual technical exchange meeting recently. The goal of the meeting was to highlight the science-based and data-driven analysis work conducted by ADAPD to advance the state-of-the-art to accelerate artificial intelligence (AI) innovation and develop AI-enabled systems to enhance the United States’...

Lab offers forum on machine learning for industry

LLNL is looking for participants and attendees from industry, research institutions and academia for the first-ever Machine Learning for Industry Forum (ML4I), a three-day virtual event starting Aug. 10. The event is sponsored by LLNL’s High Performance Computing Innovation Center and the Data Science Institute. The deadline for submitting presentations or industry use cases is June 30. The...

Virtual seminar series explores data-driven physical simulations

The rapidly growing fields of artificial intelligence (AI) and machine learning (ML) have become cornerstones of LLNL’s data science research activities. The Lab’s scientific community regularly publishes advancements in both AI/ML applications and theory, contributing to international discourse on the possibilities of these compelling technologies. The large volume of AI/ML scientific...

COVID-19 HPC Consortium reflects on past year

COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

ATOM Consortium welcomes 3 DOE national labs to accelerate drug discovery

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, of which LLNL is part, announced the U.S. Department of Energy’s Argonne, Brookhaven and Oak Ridge national laboratories are joining the consortium to further develop ATOM’s AI-driven drug discovery platform. The public-private ATOM consortium aims to transform drug discovery from a slow, sequential and high-risk...

Lab event encourages growth of women in data science

Coinciding with International Women’s Day on March 8, LLNL’s 4th Women in Data Science (WiDS) regional event brought women together to discuss successes, opportunities and challenges of being female in a mostly male field. The Lab’s first-ever virtual WiDS gathering attracted dozens of LLNL data scientists as well as some from outside the Lab, and featured speakers, a career panel and...

'Self-trained' deep learning to improve disease diagnosis

New work by computer scientists at LLNL and IBM Research on deep learning models to accurately diagnose diseases from X-ray images with less labeled data won the Best Paper award for Computer-Aided Diagnosis at the SPIE Medical Imaging Conference on February 19. The technique, which includes novel regularization and “self-training” strategies, addresses some well-known challenges in the...

CASC research in machine learning robustness debuts at AAAI conference

LLNL’s Center for Applied Scientific Computing (CASC) has steadily grown its reputation in the artificial intelligence (AI)/machine learning (ML) community—a trend continued by three papers accepted at the 35th AAAI Conference on Artificial Intelligence, held virtually on February 2–9, 2021. Computer scientists Jayaraman Thiagarajan, Rushil Anirudh, Bhavya Kailkhura, and Peer-Timo Bremer led...

Model for COVID-19 drug discovery a Gordon Bell finalist

A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

DOE announces five new energy projects at LLNL

The DOE today announced two rounds of awards for the High Performance Computing for Energy Innovation Program HPC4EI), including five projects at LLNL. HPC4EI connects industry with the computational resources and expertise of the DOE national laboratories to solve challenges in manufacturing, accelerate discovery and adoption of new materials and improve energy efficiency. The awards were...

From intern to mentor, Nisha Mulakken builds a career in bioinformatics

The COVID-19 pandemic has sparked a wave of new research and development at the Lab, and Nisha Mulakken is very busy. The biostatistician has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated...

Using models, 3D printing to study common heart defect

One of the most common congenital heart defects, coarctation of the aorta (CoA) is a narrowing of the main artery transporting blood from the heart to the rest of the body. It affects more than 1,600 newborns each year in the United States, and can lead to health issues such as hypertension, premature coronary artery disease, aneurysms, stroke and cardiac failure. To better understand risk...

Advancing healthcare with data science (VIDEO)

This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...

LLNL papers accepted into prestigious conference

Two papers featuring LLNL scientists were accepted in the 2020 International Conference on Machine Learning (ICML), one of the world’s premier conferences of its kind. Read more at LLNL News.

Lab team studies calibrated AI and deep learning models to more reliably diagnose and treat disease

A team led by LLNL computer scientist Jay Thiagarajan has developed a new approach for improving the reliability of artificial intelligence and deep learning-based models used for critical applications, such as health care. Thiagarajan recently applied the method to study chest X-ray images of patients diagnosed with COVID-19, arising due to the novel SARS-Cov-2 coronavirus. Read more at LLNL...

COVID-19 research goes public through new portal

A new online data portal is making available to the public a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of small molecules and designed antibodies for interactions with the SARS-CoV-2 virus for drug design purposes. The portal houses a wealth of data LLNL scientists have gathered from...

Interpretable AI in healthcare (PODCAST)

LLNL's Jay Thiagarajan joins the Data Skeptic podcast to discuss his recent paper "Calibrating Healthcare AI: Towards Reliable and Interpretable Deep Predictive Models." The episode runs 35:50. Listen at Data Skeptic.

Faces of STEM: Brenda Ng (VIDEO)

In this video, LLNL machine learning scientist Brenda Ng explains why she loves her job in STEM, what advice she has for others, what inspired her to go into STEM, and what she does in her free time. Watch on YouTube.

New ML platform generates novel COVID-19 antibody sequences for experimental testing

LLNL researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs. Read more at LLNL News.

Using data to build a secure future (PODCAST)

On the Hidden in Plain Sight podcast, LLNL director Bill Goldstein explains how the Lab crunches data to shape the future. Listen at Mission.org.